Evidence map›Paper›PMID 25268596›Full record

ArticlePloS one2014

ZFC3H1, a zinc finger protein, modulates IL-8 transcription by binding with celastramycin A, a potential immune suppressor.

Takeshi Tomita, Katsuaki Ieguchi, Frédéric Coin, Fredric Coin, Yasuhiro Kato, Haruhisa Kikuchi, Yoshiteru Oshima, Shoichiro Kurata, Yoshiro Maru

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Takeshi TomitaDepartment of Pharmacology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
Katsuaki IeguchiDepartment of Pharmacology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
Frédéric Coin
Fredric CoinIGBMC, Department of Functional Genomics and Cancer, CNRS/INSERM/Universite de Strasbourg, Strasbourg, France.
Yasuhiro KatoGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Haruhisa KikuchiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Yoshiteru OshimaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Shoichiro KurataGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Yoshiro MaruDepartment of Pharmacology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
Tohoku University · JPTokyo Women's Medical University · JPInstitut de génétique et de biologie moléculaire et cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Celastramycin A, a small molecule that inhibits the production of antibacterial peptides in an ex vivo culture system of Drosophila, suppresses the TNFα-mediated induction of IL-8 in mammalian cells. To understand its molecular mechanism, we examined Celastramycin A binding proteins and investigated their biological functions. Our screening and subsequent pull-down assay revealed ZFC3H1 (also known as CCDC131 or CSRC2), an uncharacterized zinc finger protein, as a Celastramycin A binding protein. The knockdown of ZFC3H1 reduced IL-8 expression levels in the TNFα-stimulated lung carcinoma cell line, LU99, and UV-irradiated HeLa cells. Based on reporter assay results, we concluded that ZFC3H1 participates in the transcriptional activation of IL-8. The findings of our UV-irradiation experiments implied that ZFC3H1 may indirectly interact with ERCC1 in an activated DNA repair complex. Thus, we designated ZFC3H1 as a mammalian target of Celastramycin A (mTOC).

Indexed as

Cell Line, TumorDNA-Binding ProteinsEndonucleasesGene ExpressionHeLa CellsHumansInterleukin-8PhosphoproteinsProtein BindingPyrrolesResorcinolsRNA InterferenceRNA, Small InterferingRNA StabilitySignal TransductionTranscriptional Activationcelastramycin ADNA-Binding ProteinsEndonucleasesERCC1 protein, humanInterleukin-8PhosphoproteinsPyrrolesResorcinolsRNA, Small InterferingTranscription FactorsTumor Necrosis Factor-alphaZFC3H1 protein, human

Identifiers

PMID25268596
PMCPMC4182580
OpenAlexW1969938254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.